Axonal transport defects and axonopathy are prominent in early pre-clinical stages of Alzheimer's disease (AD), often preceding known disease-related pathology by over a year. As epigenetic transcriptional regulatory mechanisms such as histone acetylation are critical for neurogenesis, it is postulated that their misregulation might be linked to early pathophysiological mechanisms that contribute to AD. The histone acetyltransferase (HAT) Tip60 epigenetically regulates genes enriched for neuronal functions and is implicated in AD via its formation of a transcriptional regulatory complex with the amyloid precursor protein (APP) intracellular domain. Disruption of APP function is associated with axonal transport defects, raising the possibility that an epigenetic role for Tip60 might also be involved. Here, we examine whether Tip60 HAT activity functions in axonal transport using Drosophila CNS motor neurons as a well characterized transport model.
INTRODUCTION
Epigenetic mechanisms of gene control via histone acetylation regulate neuronal patterning and activity during neurogenesis that influence cognitive function (Carrozza et al., 2003; Wang et al., 2010) . It remains unclear; however, which specific histone acetyltransferase (HAT) enzymes control these processes. The HAT Tip60 functions in chromatin-mediated processes including gene regulation and apoptosis, with emerging roles in neuronal function (Sapountzi et al., 2006; Squatrito, 2006) . We previously reported that Tip60 HAT activity is required for neuronal gene control (Lorbeck et al., 2011) regulation of synaptic plasticity , sleep (Pirooznia et al., 2012a) , and apoptosis in the Drosophila central nervous system (CNS) (Pirooznia et al., 2012b) . Accordingly, Tip60 is implicated in the neurodegenerative disorder Alzheimer's disease (AD) via its formation of a transcriptional regulatory complex with the AD associated amyloid precursor protein (APP) intracellular domain (AICD) (Cao and Sudhof, 2001; Slomnicki, 2008) . Aberrant epigenetic regulation of certain genes has been linked to AD, suggesting that Tip60 dependant mechanisms may underlie the disorder (Baek et al., 2002) . In support of this concept, we reported that Tip60 HAT activity mediates APP induced neuronal cell death in the CNS of an AD Drosophila model via misregulation of apoptosis linked genes (Pirooznia et al., 2012b) .
Accumulating evidence suggests that cognitive impairment in AD and nervous system processes affecting neural connections and activity are disrupted during early stages of the disease (Trinchese et al., 2008) . Axonopathy and axonal transport defects are commonly observed in early pre-clinical stages of AD, often preceding amyloid deposition and neuronal cell death by over a year in mouse AD models (Stokin GB, 2005) . Accumulation of axonal transport defects is believed to contribute to neurodegenerative disorder progression by triggering apoptotic pathways that lead to loss of neural activity (Roy et al., 22005; Duncan and Goldstein, 2006; Stokin and Goldstein, 2006) . Early epigenetic transcriptional regulatory mechanisms involving histone acetylation are critical in neurogenesis and as such, their misregulation may contribute to early pathophysiological mechanisms underlying progressive cognitive disorders (Sweatt; Levenson et al., 2004; Peleg et al., 2010) . Disruption of APP function has been linked to axonal transport defects (Torroja et al., 1999; Gunawardena and Goldstein, 2001) , raising the possibility that an epigenetic role for Tip60 might also be involved.
Here, we investigate whether Tip60 plays a role in axonal transport using Drosophila CNS motor neurons as a well characterized transport model (Budnik and Ruiz-Canada, 2006) . We show that loss of Tip60 HAT activity in the nervous system causes axonopathy associated with misregulation of axonal transport linked Tip60 direct target genes. Functional consequences of these defects are evidenced by reduced locomotor activity of mutant Tip60 larvae and these phenotypes can be rescued with certain HDAC inhibitors. We show that Tip60 function in axonal transport is mediated by APP and that excess Tip60 exerts a neuroprotective role in APP induced axonal transport defects. Our observations highlight an interactive role between Tip60 and APP in axonal transport and provide insight into understanding epigenetic HAT based mechanisms underlying early pathophysiology of AD.
MATERIALS AND METHODS

Fly stains and crosses
All fly lines used were raised under standard conditions at 22°C on standard yeasted drosophila media (Applied Scientific Jazz Mix Drosophila Food, Thermo Fisher Scientific). The pan-neuronal driver elav c155 and the motor neuron specific driver D42 were obtained from Bloomington Stock Center (Bloomington, IN). Independent transgenic fly line dTip60 WT (line C), dTip60 E431Q (independent lines A and B), dTip60 RNAi (line A) were created as previously described (Zhu et al., 2007; Lorbeck et al., 2011) . Rescue lines dTip60 Rescue B and dTip60 Rescue C were generated and fully characterized as previously reported (Lorbeck et al., 2011) . dTip60 Rescue B is the dTip60 E431Q B fly line containing an extra copy of dTip60 WT crossed and dTip60 Rescue C is the dTip60 E431Q A fly line containing an extra copy of dTip60 WT . APP; dTip60 E431Q (independent lines A and B), APP dCT;dTip60 E431Q (independent lines A and B); APP; dTip60 WT (line C), and APP dCT;dTip60 WT (line C) were created as previously described by standard genetic crosses (Pirooznia et al., 2012b) . The fly line containing elav-GAL4-syteGFP was a generous gift from Dr. Kendal Broadie (Vanderbilt University). All experimental crosses were carried out at normal physiological temperature of 25°C.
Larval motor function assays
Wandering third instar larvae were used for all larval motor function assays. The following three larval motor function assays were performed as previously described by (Mudher et al., 2004) to quantify locomotor dysfunction. Prior to the start of the test, the larvae are placed on a petri dish containing 1% agarose and allowed to equilibrate for 5 minutes. In the contraction assay, the number of full body peristaltic contractions performed in 30 seconds was recorded. In the righting assay, larvae were turned ventral side up and the time taken to return to the crawling position was recorded. In the line crossing assay, the number of lines crossed by the head of a larva in 30 seconds on a grid 0.4 cm × 0.4 cm was recorded. At least 30 larvae were tested in each locomotor assay three times and unpaired Student's t-test was used for statistical analysis.
Axonal transport analysis
Wandering third instar larvae were dissected in HL-3 saline, pH 7.2 and pinned out on Sylgard dishes by cutting along the length of the dorsal midline and removing the digestive track and trachea in order to expose the CNS. Fillet preparations were fixed in 3.5% paraformaldehyde for 30 minutes, followed by 3 washes in PBS (10 minutes each), then mounted onto slides with Vectashield antifade mounting media (Vector laboratories).
Imaging of Axonal transport analysis
Quantitative analysis of larval motor neurons was carried out as follows. Five different nerves were selected from the region immediately posterior to the brain. Larval motor neurons were imaged on an Olympus (Germany) FV1000 laser scanning confocal microscope. All images were captured using same constant confocal gain settings. Images were acquired as a Z-stack and then rendered as a maximum projection. The nerves were analyzed by counting synaptotagmin accumulations with a diameter of at least 0.7μm along a segment of at least 50μm. In the analysis, each genotype is represented by 10 to 15 larval fillet preparations. For comparison between genotypes, all samples were processed simultaneously and imaged using identical microscopic acquisitions parameters. Upaired Student's T-test was used for statistical analysis.
Immunohistochemistry and Imaging Analysis
3 rd instar larvae were filleted in HL-3 saline, pH 7.2 and pinned out on Sylgard dishes with guts removed. Fillet preparations were fixed in 3.5% paraformaldehyde for 30 minutes, followed by 3 washes in PBS and one with 1× PBS with 0.1% Triton. The larvae were then incubated overnight in primary antibody overnight at 4°C. The primary mouse monoclonal anti-acetylated tubulin (1:1000) antibody was obtained from Sigma-Aldrich. After 6 washes in PBS-T (1× phosphate buffered saline +0.1% Triton), fillets were incubated in 2° antibody for 1 hour, washed twice in 1× PBS-T, once in 1× PBS, then mounted onto slides in Vectashield antifade mounting media (Vector laboratories). Confocal microscopy was performed using an Olympus Microscope with fluoview software. All images were captured using same constant confocal gain settings. Images were acquired as a Z-stack and then rendered as a maximum projection. In the analysis, each genotype is represented by 10 to 15 larval fillet preparations. For comparison between genotypes, all samples were processed simultaneously and imaged using identical microscopic acquisitions parameters. Quantitative analysis of fluorescence intensities was done using FV1000 software. All images were corrected for background before intensity measurements were carried out. Unpaired student's T-test was used for statistical analysis.
Real-time PCR analysis
Total RNA was isolated from wandering third instar dTip60 E431Q B and wildtype larvae using the RNeasy Plus Mini Kit (Qiagen). cDNA was prepared using the SuperScript II reverse transcriptase kit (Invitrogen) according to the manufacturer's instructions with 1 μg total RNA and 0.2 μg/ml random hexamer primers (Roche Applied Science). PCR reactions were performed in a 20 μl reaction volume containing cDNA, 1 × Power SYBR Green PCR Master Mix (Applied Biosystems), and 10 μM both forward and reverse primers (primer pairs available upon request). PCR was performed using an ABI 7500 Real-Time PCR system (Applied Biosystems) following the manufacturer's instructions. Fold change in mRNA expression was determined by the ΔΔCt method (Livak and Schmittgen, 2001 ).
Chromatin Immunoprecipitation and qPCR analysis
Chromatin from third instar larval heads was prepared as follows. Approximately 300 third instar larval heads for each genotype were homogenized first with a pestle and then using a potter homogenizer (5 strokes) containing homogenization buffer (60mM KCl, 15mM NaCl, 4mM MgCl 2 , 15mM Hepes (pH 7.6), 0.5% Triton X-100, 0.5mM DTT, Protease and phosphatase inhibitors cocktail (Roche). Cross-linking was carried out for 15 mins by adding formaldehyde to a final concentration of 1.8%. Cross-linking reaction was stopped by adding glycine solution (final concentration of 225mM) followed by incubation on ice for 5 mins. Fixed tissue homogenate was then washed 3× homogenization buffer and 1× in lysis buffer (140mM NaCl, 15mM Hepes (pH 7.6), 1mM EDTA, 0.5mM EGTA, 1%Triton X-100, 0.5mM DTT, 0.1% sodium deoxycholate, protease and phosphatase inhibitors (Roche), 1mM PMSF and 10mM sodium butyrate). Next, lysis buffer containing SDS (0.1%) and sodium lauryl sarcosine (0.5%) was added to the homogenate and incubated for 10 mins at 4°C. After incubation, the cells were disrupted by 8 pulses for 30secs each on ice using a tip sonicator (Fisher Scientific Sonic Dismembrator 50 Ultrasonic Homogenizer) yielding sheared chromatin fragments ranging from 200-500bp. The sheared chromatin was then incubated at 4°C for 10 mins and centrifuged twice, yielding the final chromatin extract for chromatin immunoprecipitation (ChIP).
Chromatin precipitation assays were performed using ChIP-IT Express Kit (Active Motif), following the manufacturer's instructions. Briefly, ChIP was carried out with 20ug sheared chromatin for H4 pan-acetylated Antibody (1:150) (AbD Serotec) and 30ug sheared chromatin for Tip60 antibody (2ug) (Abcam). A mock reaction containing all reagents except the antibody was carried out simultaneously for each sample as a control. The chromatin was immunoprecipated using the ChIP IT Express kit (Active Motif) exactly following the manufacturer's specifications. The eluted material from the immunoprecipitation was then purified using QIAquick PCR purification kit (Qiagen) and was directly used for real-time PCR.
PCR reactions were performed in triplicate a 20 μl reaction volume containing 10 ul of SYBR green PCR master mix (Applied Biosystems), 1 ul of DNA template and 0.5 uM each of forward and reverse primer for each gene sequence (primer pairs available upon request). Quantitative PCR was performed on an ABI 7500 Real Time PCR System (Applied Biosystems) according to the manufacturer's instructions. For each primer set, fold enrichment was calculated using the slope of a standard curve according to the manufacturer's instructions in the ChIP-IT Express kit. Briefly, a standard curve was generated from serial 10 fold dilutions of the Input DNA. The Ct values were used to estimate DNA quantity of the ChIP and no antibody mock control samples. Fold enrichment was calculated as a ratio of the DNA quantity in the ChIP and no antibody mock control.
Drug treatment
Dried potato food (Carolina Biological Supply Company) was made in 3mL of water with the desired final concentration of the following HDAC inhibitors: ms-275 (LC laboratories), Sodium butyrate (LC Laboratories), SAHA (LC Laboratories), Givinostat (Selleck Chemicals), Valproic acid (Selleck Chemicals), Romidepsin (Selleck Chemicals), Mocetinostat (Selleck Chemicals), or no drug (all drug concentrations used available upon request). Mated flies for each genotype were allowed to lay eggs on drug treated food until the third instar stage in which they were used for the relevant experiments. Dose response curve experiments were performed on wild-type larvae using different titrations of each drug and the highest concentration of drug that caused no observable locomotion defects in wildtype larvae was selected for use.
RESULTS
Loss of dTip60 HAT function in the central nervous system impairs larval locomotor function
We previously demonstrated that dTip60 is robustly expressed in the embryonic ventral midline cells destined to become the motor neurons (Lorbeck et al., 2011) . To test whether Tip60 HAT activity is required for motor neuron function, the GAL4-targeted system was used to modulate dTip60 HAT activity levels in the nervous system and a series of functional locomotion assays carried out. Misregulation of dTip60 was achieved for all experiments by utilizing the GAL4/UAS targeted gene expression system with flies carrying UAS responsive transgenes for either wild-type dTip60 (dTip60 WT ), dTip60 RNAi (Zhu et al., 2007; Sarthi and Elefant, 2011; Pirooznia et al., 2012b) , or a dominant negative HAT defective version of dTip60 E431Q using independent fly lines dTip60 E431Q A and B that express low and high levels of the dTip60 E431Q transgene, respectively (Lorbeck et al., 2011) . Fly lines dTip60 RNAi , dTip60 E431Q , dTip60 WT , and w 1118 control flies were each crossed to the presynaptic pan-neuronal driver GAL4 driver elav C155 . Initial qualitative observations of motor function in wandering third instar larvae showed that flies with reduced dTip60 HAT function exhibited slow, sluggish, and disjointed movements. The most severely affected larvae exhibited posterior paralysis and a distinctive tail flipping phenotype which causes the larvae to rhythmically flip their tails upward while crawling. This phenotype is reminiscent to those described for mutants with known defects in vesicle transport machinery such as Kinesin heavy chain (Hurd and Saxton, 1996) and Kinesin light chain (Gindhart et al., 1998) mutants.
To quantify such locomotor dysfunction, a series of three larval motor function assays were carried out as previously described (Mudher et al., 2004) . Contraction capability, speed of locomotion, and ability to perform a complex motor task such as righting provide direct, quantifiable evidence of motor neuron function. In the contraction assay, the number of full body peristaltic contractions performed in 30 seconds was recorded. In the righting assay, larvae were turned ventral side up and the time taken to return to the crawling position was recorded. In the line crossing assay, the number of lines crossed by the head of a larva in 30 seconds on a grid 0.4 cm × 0.4 cm was recorded. Our results show that induction of dTip60 RNAi and dTip60 E431Q in the nervous system using the GAL4 driver C 155 resulted in larvae that were significantly less mobile and crossed proximately half as many grid lines when compared to control wild type larvae from a w 1118 x elav-GAL4 cross ( Figure 1A ), performed significantly fewer full body peristaltic contractions ( Figure 1B ), and took on average three times longer to return to the crawling position ( Figure 1C ). Similar results were obtained when dTip60 RNAi and dTip60 E431Q were induced using the motor neuron specific GAL4 driver D42 ( Figure 1D ), confirming that these locomotion defects were specifically due to loss of motor neuron function. Induction of dTip60 WT had no effect on locomotor ability ( Figure 1A-C) . Moreover, dTip60 RNAi A and dTip60 E431Q locomotor defects were fully rescued by an additional copy of dTip60 WT ( Figure 1A -C), indicating that the phenotypic effects we observe are specifically caused by disruption of Tip60 HAT function. Taken together, these results suggest that loss of dTip60 function in the nervous system, and specifically in the motor neurons, results in locomotor dysfunction in the fly.
Nervous system specific disruption of Tip60 HAT activity causes vesicle accumulations in motor axons extending from the CNS The tail flipping phenotype and locomotion defects that result from disruption of Tip60 HAT activity are reminiscent of nervous system defects linked to mutations in genes required for axonal vesicle transport machinery. These finding prompted us to assess whether axonal transport was perturbed by misregulation of Tip60 HAT activity by utilizing double transgenic flies co-expressing a synaptotagmin-e-GFP fusion protein (syt-eGFP) along with either dTip60 E431Q or dTip60 WT under the control of the pan neuronal elav-GAL4 driver. Synaptotagmin is an integral synaptic vesicle protein, and thus the syt-eGFP fusion protein serves as a well characterized marker to assess synaptic vesicle transport along the axons in the fly (Zhang et al., 2002) . As axonal transport defects often manifest as axonal swellings or spheroids corresponding to axonal enlargements and aberrant accumulations of axonal cargos (Stokin GB, 2005) , such axonopathy can be readily identified and quantitated using the syt-eGFP fusion protein. Third instar wandering larvae were dissected to expose motor axons extending from the central nervous system, and confocal imaging was used to assess the distribution of GFP-tagged axonal vesicles. In control elav-GAL4-syt-eGFP larvae, GFP-tagged vesicles were evenly distributed through the length of the motor neuron (Figure 2A ) including the main intersegmental regions, the second-order nerve branches, and the neuromuscular junction (NMJ) where they were localized normally into boutons. In contrast, larvae expressing dTip60 E431Q revealed the formation of aggregations of GFP-tagged vesicles ( Figure 2B -C) thought to reflect defective passage of transport vesicles in peripheral axons (Gunawardena and Goldstein, 2001 ). As the diameter of an axon is approximately 0.5 μm, abnormal axonal aggregations thought to disrupt axonal transport are defined as those larger than 0.7μm per 50um of axonal length (Rusu et al., 2007) . Quantification revealed a significantly larger number of these aggregates in flies expressing either dTip60 E431Q construct ( Figure 2G ) when compared to control, dTip60 WT , and dTip60 Rescue flies where virtually no accumulations were observed ( Figure  2A ,D,E,F). Taken together, these results demonstrate that dTip60 HAT activity is required for synaptic vesicle transport along the motor axons in the fly.
Tip60 HAT activity loss in the CNS does not impact tubulin acetylation status in the motor axons where vesicle stalling takes place
Acetylation of α-tubulin within microtubules (MTs) is believed to regulate motor-dependent trafficking of cargo along neuronal axons (Hammond et al., 2008) by serving as a guidance cue for specific motors in which polarity has not yet fully been determined (Janke and Kneussel, 2010) . In this regard, we previously reported that loss of Tip60 within the fly neuromuscular junction (NMJ) results in reduction of acetylated microtubules only at ends of axons specifically extending into the terminal synaptic boutons in conjunction with defects in bouton growth and development . Thus, we asked whether MT acetylation was also reduced within the motor axons in the Tip60 HAT mutant flies as this might account for the vesicle accumulations we observe. To address this question, we performed immunohistochemical staining of the Drosophila motor neurons with anti-acetylated tubulin, which specifically recognizes α-tubulin in the acetylated state. For these and all subsequent studies, we chose to use fly line dTip60 E431Q B as it expresses the most robust levels of dTip60 E431Q of all fly lines tested, and accordingly, produces the most severe lethal phenotype and displays significantly depleted endogenous levels of acetylated H4 (Lorbeck et al., 2011) . When larvae expressing dTip60 E431Q B were compared to w 1118 control larvae, the acetylated microtubule network appeared similar and importantly, was present along the entire length of the motor axons where vesicle clogging is observed in dTip60 E431Q larvae ( Figure 3A-D) . Quantitation of the mean fluorescence intensity of anti-acetylated tubulin staining in these flies revealed that there was no significant difference between dTip60 E431Q and control w 1118 fly lines ( Figure 3E ). These findings suggest that the synaptic vesicle clogging we observe within the motor axons in the dTip60 E431Q fly line is not the result of reduced microtubule acetylation in these regions of the axons and may be mediated by another mechanism.
Tip60 HAT activity in the CNS is required for the transcriptional regulation of genes linked to axonal vesicle transport
Our previous analysis demonstrated that expression of dTip60 E431Q results in the misregulation of genes enriched for nervous system function (Lorbeck et al., 2011) . As no changes were detected in the acetylation status of α-tubulin within the motor axons of dTip60 E431Q flies, we hypothesized that a potential mechanistic basis for the axonal transport phenotype caused by Tip60 HAT loss was due to inappropriate expression of genes required for axonal transport. To test this hypothesis, we re-analyzed our previously published microarray gene expression data that compared changes in gene expression caused by ubiquitous induction of Tip60 E431Q in whole larvae (Lorbeck et al., 2011) to specifically identify axonal transport linked genes that are misregulated in response to Tip60 HAT loss. Our analysis using the Panther classification system identified 34 genes that were functionally linked to axonal transport (Table 1) . Among these, genes that encode members of Kinesin and Dynein super families of motor proteins were highly represented. Intriguingly, many of the identified genes were associated with Alzheimer's, Parkinson's, and Huntington's diseases, all neurodegenerative disorders in which aggregation of vesicles due to axonal transport stalling and locomotor dysfunction are a common characteristic (Roy et al., 2005; Duncan and Goldstein, 2006) .
To extend and confirm our microarray analysis, we carried out quantitative real-time PCR analysis of six of these genes ( Figure 4A ) that were representative of a particular pathway or protein family member ( Figure 4B ) this time using staged dTip60 E431Q third instar brain tissue under the control of the elav-GAL4 driver. Khc (Kinesin heavy chain) and Klp64D (Kinesin-like protein at 64D) were two confirmed gene targets significantly upregulated and downregulated, respectively, in response to Tip60 HAT loss that have roles in anterograde transport (Hurd and Saxton, 1996; Ray et al., 1999) . Additional upregulated targets included genes with established roles in retrograde transport such as Dhc64C (Dynein heavy chain 64C) and Glued (p150 glued ), a dynactin component that serves as an adaptor to link cargo to dynein for transport. Similar to our Tip60 mutant phenotypes, abnormal activation of cytoplasmic dynein heavy chain (Dhc64C) and the p150 Glued (Glued) component of the dynactin complex result in axonal stalling and posterior paralysis (Martin et al., 1999) . Downregulated targets with confirmed roles in axonal vesicle transport included Synaptotagmin 1 (Syt1), an integral synaptic vesicle protein required for vesicular trafficking, exocytosis, and neurotransmitter release (Martin et al., 1999) and Appl, the Drosophila homologue of human APP. Intriguingly, both reduction and excess Appl and APP in flies causes axonal vesicle transport stalling and locomotor defects almost identical to the phenotypes we observed in our Tip60 HAT mutant larvae (Torroja et al., 1999; Gunawardena and Goldstein, 2001 ). In summary, our identification of axonal vesicle transport and locomotor linked genes that are misregulated in the larval brain in response to Tip60 HAT loss support a transcriptional regulatory role for dTip60 in these neuronal processes.
Certain HDAC inhibitors rescue both locomotor dysfunction and axonal vesicle accumulations in Tip60 HAT mutant larvae
The effects of Tip60 HAT reduction on locomotion and axonal transport prompted us to investigate what effect HDAC inhibitors might have on the flies. We hypothesized that if reduction of Tip60-induced acetylation levels in dTip60 E431Q HAT mutant larvae is a mechanism underlying axonal transport defects, then an HDAC inhibitor could partially rescue these defects by maintaining and/or increasing global acetylation levels in these Tip60 HAT mutant flies. To test this hypothesis, larvae were reared on food containing one of seven types of HDAC inhibitors (ms-275, Sodium butyrate, SAHA, Givinostat, Valproic acid, Romidepsin, or Mocetinostat). To select an appropriate concentration of drug that was not toxic to the larvae, dose response curve experiments were performed on wild-type larvae using different titrations of each drug and the highest concentration of drug that caused no observable locomotion defects in wild-type larvae was selected for use.
Interestingly, although all seven types of HDAC inhibitors tested were classified as inhibitors of either class I or both class I and II HDACs, only treatment of larvae with ms-275, Givinostat, or Mocetinostat showed significant rescue for locomotor ability as assessed by line crossing and contraction ability assays ( Figure 5A,B) . Moreover, only larvae treated with ms-275, Givinostat, and Mocetinostat showed rescue of the axonal transport phenotype ( Figure 5C -G). These results reveal that although the inhibitors tested were classified as similar in terms of the HDAC classes they target (Chuang et al., 2009) , they showed differences in their efficacy for treatment of axonal vesicle stalling and corresponding behavioral defects, in vivo.
Ms-275 treatment restores histone H4 chromatin acetylation levels at Tip60 misregulated target genes in Tip60 HAT mutant larvae
The rescue of the locomotor function and axonal vesicle accumulations by selective HDAC treatment prompted us to ask whether a possible mechanism for the drug's action was via rescue of axonal transport linked genes that were misexpressed in response to Tip60 HAT loss. To address this question, we carried out quantitative real-time PCR analysis on the six confirmed Tip60 targets we had identified ( Figure 4B ), this time using staged dTip60 E431Q third instar brain tissue dissected from larvae reared on ms-275. For these and all subsequent studies, we opted to use ms-275 treatment as it showed strong efficacy in axonal defect treatment and is the most well characterized drug we tested in terms of its nervous system specificity (Simonini et al., 2006) . Out of the six genes tested, mRNA levels of Appl and Synaptotagmin 1 in ms-275 treated Tip60 E431Q expressing brains showed no significant difference when compared to wild-type levels ( Figure 6A ), indicating that ms-275 rescued expression of each of these genes. Taken together, these results demonstrate that treatment of larvae expressing dTip60 E431Q in the nervous system with the brain specific HDAC inhibitor ms-275 rescues both locomotion phenotypes and axonal vesicle accumulations, possibly by inducing the expression levels of at least some genes important in regulating these processes.
The six genes were further analyzed to establish possible mechanisms underlying their transcriptional regulation. As each of these genes was misexpressed due to Tip60 HAT loss, we first asked whether these candidate genes were indeed direct targets of Tip60 in wildtype control flies (w 1118 ) and whether Tip60 recruitment to these gene loci was affected in dominant negative Tip60 HAT mutant flies (dTip60 E431Q ). To address these questions, chromatin was isolated from larval posterior head regions from each of these genotypes and ChIP-qPCR analysis was used to detect in vivo binding of Tip60 at each of these gene loci. This analysis revealed significant enrichment for Tip60 binding in vivo at four of the six gene loci tested in control w 1118 larvae, thus classifying these genes (Appl, Dhc64C, Khc and Syt1) as novel direct Tip60 targets and Glued, and Klp64D as indirect Tip60 targets Figure 6B ). In contrast, dTip60 E431Q larvae showed no enrichment for Tip60 binding at any of these gene loci ( Figure 6B ).
Regulation of histone acetylation levels is a key mechanism by which Tip60 and HDAC inhibitors exert their action on gene control. Therefore, we hypothesized that acetylation levels at Tip60 direct target genes would be enhanced in control w 1118 flies when compared to dTip60 E431Q where Tip60 recruitment is lacking, and that treatment of dTip60 E431Q flies with ms-275 HDAC inhibitor would restore acetylation levels at these targets genes. To test this, we assessed enrichment levels of pan-acetylated histone H4 which is the preferential histone target of Tip60, at each gene loci in w 1118 , dTip60 E431Q and ms-275 treated dTip60 E431Q larvae in chromatin isolated from larvae heads. We found that H4 acetylation enrichment levels at all Tip60 target genes were enhanced in the w 1118 flies and significantly decreased in dTip60 E431Q flies ( Figure 6C ). As predicted, treatment of dTip60 E3431Q larvae with ms-275 partially rescues acetylation loss at all but one (Appl) of the genes ( Figure 6C ). Of note, we did observe enrichment of H4 acetylation at Tip60 indirect targets (Glued, Klp64D) relative to that found in dTip60 E431Q larvae, suggesting that perhaps Tip60 may indirectly lead to increased H4 acetylation or non-enrichment for Tip60 site specific acetylation at these sites is masked by the global pan-acetylation H4 antibodies used in these studies. Taken together, these results demonstrate that reduction of Tip60 HAT activity lead to reduced histone H4 acetylation levels at Tip60 gene targets that can be partially rescued by treatment with the ms-275 HDAC inhibitor.
Tip60 and APP functionally interact in the nervous system to mediate locomotion ability and axonal vesicle transport
We previously reported that Tip60 and APP functionally interact to mediate nervous system development and apoptotic cell death in the CNS of a Drosophila Alzheimer's disease model (Pirooznia et al., 2012b) . Given our finding that Appl expression is downregulated in the larval brain in response to Tip60 HAT loss, and that Tip60 and APP misexpression each separately cause similar defects in axonal vesicle transport in larvae, we hypothesized that these proteins might act together to mediate this process. To test this hypothesis, we utilized unique UAS responsive transgenic fly lines generated in our lab (Pirooznia et al., 2012b ) that co-express equivalent levels of dTip60 E431Q and APP or dTip60 E431Q and APP dCT (APP lacking the C-terminus Tip60 interacting domain). Functional behavior analysis of these larvae using locomotion assays revealed a synergistic interaction between Tip60 and APP as co-expression of dTip60 E431Q with APP resulted in locomotion phenotypes nearly four-fold relative to that observed in larvae expressing APP or dTip60 E431Q alone ( Figure  7A -C). These fly lines were then crossed to flies containing the synaptotagmin-e-GFP fusion protein transgene (syt-eGFP) under the control of the pan neuronal elav-GAL4 driver to track axonal vesicle transport in response to misexpression of both Tip60 and APP (Zhang et al., 2002) . Confocal imaging analysis of motor axons was used to assess the distribution of GFP-tagged axonal vesicles in the motor axons extending from the CNS in third instar larvae. Consistent with the above result, quantitative analysis of vesicle accumulations in larvae overexpressing both dTip60 E431Q and APP revealed an exacerbated phenotype indicative of a synergistic genetic interaction between the two proteins ( Figure  8I ). Vesicle accumulations were approximately four fold higher in larvae co-expressing dTip60 E431Q and APP than in larvae expressing dTip60 E431Q or APP alone ( Figure 8B,C,E) . Importantly, and as we predicted, the Tip60 and APP interaction was dependent upon the Cterminus of APP that interacts with Tip60 (Cao and Sudhof, 2001 ) as co-expression of dTip60 E431Q and APP dCT resulted in a moderate level of vesicle accumulations and locomotor dysfunction that was approximately equivalent to that observed for dTip60 E431Q alone ( Figure 7A -C, Figure 8B,D,F) .
We previously demonstrated that dTip60 displays a neuroprotective role in AD neurodegenerative pathology in that increased levels of dTip60 HAT activity can suppress APP induced apoptotic cell death in the CNS of a fly AD model (Pirooznia et al., 2012b) . These findings prompted us to ask whether elevated Tip60 HAT levels would also suppress the APP induced axonal transport and locomotor defective phenotypes. To address this question, we performed axonal transport assays and functional larval locomotion assays in third instar larvae co-expressing both dTip60 WT and APP using our APP; dTip60 WT line C that expresses the highest levels of wild type Tip60 for all of our dTip60 WT lines (Pirooznia et al., 2012b) . Remarkably, we found that additional levels of Tip60 partially rescued APP induced vesicle aggregation as evidenced by a significant reduction of the presence of vesicle accumulations in the motor neurons of larvae expressing both APP and dTip60 WT when compared to APP alone ( Figure 8B,G,H) . Functional analysis of the Tip60 and APP interaction using locomotion assays demonstrated that excess levels of dTip60 WT also partially rescued APP induced locomotor defects ( Figure 7A-C) . Importantly, and as we predicted, partial rescue of APP induced axonal vesicle transport and locomotor defects was dependent upon the Tip60 interacting C-terminus of APP, as larvae co-expressing both dTip60 WT and APP-dCT do not show this rescue (Figure 7A-C) . Taken together, these results demonstrate that Tip60 and APP functionally interact to mediate motor axon vesicle transport and locomotor function in larvae, and that this interaction is dependent upon the Tip60 interacting C-terminus of APP.
DISCUSSION
Previously, we demonstrated that Tip60 HAT activity mediates APP induced lethality and apoptotic cell death in the CNS of an Alzheimer's disease (AD) fly model (Pirooznia et al., 2012b) . Here, we further examine this functional interaction in neuronal development by testing the hypothesis that Tip60 and APP functionally interact to mediate axonal synaptic vesicle transport, a process shown to involve APP itself (Torroja et al., 1999; Gunawardena and Goldstein, 2001; Stokin GB, 2005) . We show that loss of dTip60 HAT function in the CNS causes synaptic vesicle accumulations in motor axons extending from the CNS and associated locomotor function defects, supporting a role for Tip60 HAT activity in these processes. Further, we found that Tip60 HAT mutant induced locomotion and transport defects are exacerbated by APP, while excess Tip60 rescues APP mediated axonal transport defects, supporting a functional interaction between these proteins in these processes. Directional motor dependent trafficking is believed to be controlled, at least in part, by acetylation of α-tubulin within microtubules (MTs) that is associated with stable MT and serves as a guidance cue to allow for polarity determination (Janke and Kneussel, 2010) . In this regard, we previously reported that Tip60 HAT loss within the fly neuromuscular junction (NMJ) results in reduction of acetylated microtubules only at ends of axons specifically extending into the terminal synaptic boutons in conjunction with defects in bouton growth and development . However, we detected no changes in the α-tubulin acetylation levels along the entire length of the motor axons in dTip60 E431Q larvae where vesicle clogging is observed; suggesting that Tip60 mediates its function in vesicle transport, at least in part, via epigenetic control of axonal transport linked genes. In support of this concept, we identified a number of axonal transport linked genes that were misregulated in response to dTip60 HAT loss. Inappropriate Tip60/APP-AICD complex formation and/or its recruitment to chromatin may contribute to AD-linked neurodegeneration by causing aberrant epigenetic marks with subsequent negative effects on neuronal gene expression profiles (Baek et al., 2002; Hebert et al., 2006) . In support of this concept, we recently reported that expression of certain AD linked Tip60 gene targets critical for regulating apoptotic pathways are modified by excess APP in an AD fly model (Pirooznia et al., 2012b) . Thus, our results support a model for APP in inducing axonal transport defects via misregulation of the Tip60/AICD complex required for transcriptional regulation of Tip60 genes linked to transport function such as motor proteins.
Loss of HAT activity in the CNS is accompanied by transcriptional dysfunction that causes neuronal malfunction and (Levenson and Sweatt, 2005) and is associated with a number of disorders of human cognition including Rubinstein-Taybi syndrome (Petrij et al., 1995) , schizophrenia (Chen et al., 2002) , and more recently, AD (Pirooznia et al., 2012b) . Numerous studies have examined the efficacy of histone deacetylase inhibitors (HDACi) as therapeutics for treatment for cognitive disorders. HDACi often upregulate general acetylation to relieve transcriptional repression (Kim et al., 2000; Richon et al., 2000) which facilitate cell survival. Specific HDAC inhibitors have been shown to partially rescue dendritic spine reduction associated with memory loss in a mouse model of AD as well as expression of several plasticity related proteins (Ricobaraza et al., 2012) . However, although advances have been made to design more selective HDAC inhibitors, there is some speculation about the target specificity of HDAC inhibitors as they predominantly function by inhibiting classes of proteins, some with multiple non-redundant functions (Selvi et al., 2010) . Thus, the current use of pan-HDAC inhibitors that act by increasing global acetylation levels can also disrupt cellular acetylation homeostasis with subsequent negative consequences. Moreover, targeting a particular class of HDACs is an arduous task as the causative agents of memory impairing histone acetylation changes and hence, the best targets for pharmacological strategies, remain unknown (Graff et al., 2012) . Here, we test the efficacy of different HDAC inhibitors in treating axonal defects, in vivo, by screening a panel of seven different HDAC inhibitors ( Figure 5) . Interestingly, although all of these inhibitors are classified to predominantly target either class I or classes I and II HDACs, only three of the HDACs we tested were able to rescue the locomotion and axonal defects we observed in Tip60 HAT mutant larvae, supporting their specificity in terms of efficacy of axonal defect treatment as well as the value of testing these drugs on specific neuronal defects using an in vivo model system.
The steady-state level of histone acetylation in the brain is dynamically maintained by the opposing actions of HATs and HDACs that are critical for transcriptional regulation and which must be stringently maintained. Alterations that disrupt the HAT/HDAC balance, and thus acetylation levels, cause transcriptional dysregulation that alters cellular homeostasis (Langley et al., 2005) . Consistent with these studies, our findings suggest that axonal defects are influenced by changes in expression of axonal transport linked genes in Tip60 HAT mutant larvae (Figure 4) . Indeed, we confirmed that four (Appl, Dhc64c, Khc, Syt1) of the six axonal transport genes were novel bona fide Tip60 direct targets as Tip60 in vivo binding was detected at their loci. In contrast, Tip60 binding was not detected at any of the gene loci in the Tip60 HAT mutant larvae with concomitant reduction of chromatin acetylation at histone H4 at these same sites. These results indicate that the HAT mutation in Tip60 both reduces endogenous histone H4 acetylation levels (Lorbeck et. al 2011) and negatively impacts recruitment of both HAT mutant and endogenous wild-type Tip60 to its target genes. Interestingly, while we found that treatment with ms-275 enhances histone H4 acetylation levels partially back to control levels at the majority of the genes tested, only two of these genes showed partial transcriptional rescue ( Figure 6A ). Conversely, although Khc was the only gene found to show full acetylation rescue at histone H4 by ms-275 treatment, it was not one of the genes that was transcriptionally rescued. Such partial rescue is consistent with our finding the while select HDAC inhibitors fully rescued axonal stalling, they only partially rescued the more complex associated behavioral locomotion phenotypes. Such partial rescue of disease linked morphology and target gene expression by an HDAC inhibitor is not without precedent, as previous studies have concluded that although HDACi treatment induces general hyperacetylation, it is often not sufficient to produce absolute beneficial effects alone. For instance, (Vecsey et al., 2007) demonstrated that general induction of histone acetylation by HDACi treatment was not sufficient to rescue synaptic plasticity and memory loss in the hippocampus of a mouse model lacking the learning and memory linked HAT CBP, and that a wild-type CBP allele in conjunction with HDACi treatment was required. Such incomplete rescue by HDACi treatment alone is likely because induction of certain synaptic plasticity target genes still require recruitment of CBP. Consistent with these findings, our results suggest that global enhancement of histone H4 acetylation by select HDACi treatment is not sufficient for full rescue of certain genes, as they may still require recruitment of Tip60 for site specific acetylation and/or for interaction with additional transcriptional factors.
Many HATs, as opposed to HDACs, have non-redundant physiological functions and are required for site specific chromatin marks that promote specific gene expression profiles (Rouaux et al., 2003) . These findings support the notion of exploring the efficacy of specific HAT modulators for use in therapeutic treatment in conjunction with HDACi, as they would have more direct and specific effects over more general HDACi treatment (Selvi et al., 2010) . Indeed, the HAT CBP has been shown to play a neuroprotective role in neurodegenerative processes linked to multiple cognition linked disorders (Rouaux et al., 2004) . Moreover, partial loss of Tip60 has recently been reported to slow the progression of spinocerebellar ataxia (Gehrking et al., 2011) . Here we report that although Tip60 overexpression alone causes no observable axonal transport phenotypes, its excess production in conjunction with APP partially rescues both APP mediated behavioral and axonal transport defects as well as APP mediated apoptotic neuronal cell death in the CNS and axonal growth that regulates sleep (Pirooznia et al., 2012a , Pirooznia et al., 2012b . Thus, our data support an all encompassing neuroprotective function for Tip60 in multiple neuronal processes that are interrupted in AD pathology. We propose that Tip60 might exert this neuroprotective function either by itself or by complexing with other peptides such as AICD for its recruitment and site specific acetylation of specific neuronal gene promoters to redirect their expression and function in selective neuronal processes such as axonal transport. Consistent with this concept, our previous study supports a model by which Tip60 and or Tip60/AICD act to induce neuroprotective and developmental genes that act together to skew cell fate from apoptotic cell death towards cell survival under neurodegenerative conditions such as excess APP (Pirooznia et al., 2012b) . Further elucidation of the fundamental role of Tip60 in neuronal processes linked to neurodegenerative diseases such as AD should help guide the generation and usage of specific HAT modulators for the treatment of cognitive disorders. Histograms representing the results of a series of locomotion assays conducted on w 1118 control third instar larvae or third instar larvae expressing each of the different GAL4 responsive transgenes under the control of the elav C155 pan-neuronal GAL4 driver for the following assays. (A) line crossing assay, (B) contraction assay, (C) righting assay. In all assays, larvae expressing dTip60 E431Q or dTip60 RNAi took significantly longer to complete the locomotor tasks and showed a significant loss of locomotor function as compared to control and dTip60 WT larvae. The defects observed in the dTip60 E431Q larvae were rescued with an additional copy of Tip60 WT (dTip60 Rescue independent lines B and C). Rescue lines dTip60 Rescue B and dTip60 Rescue C were generated and fully characterized as previously reported (Lorbeck et al., 2011) . dTip60 Rescue B is the dTip60 E431Q B fly line containing an extra copy of dTip60 WT crossed and dTip60 Rescue C is the dTip60 E431Q A fly line containing an extra copy of dTip60 WT . (D) Line crossing assay using the motor neuron specific driver D42-GAL4 driver. Statistical significance for all experiments was calculated using an unpaired Student's t-test. *P<0.05, n= 30 (A) Real time PCR was carried out on cDNA isolated from staged third instar larval dissected brain tissue from larvae expressing dTip60 E431Q under the elav C155 pan-neuronal GAL4 driver. Histogram depicts relative fold change in expression level of axonal transport related target genes in brain of larvae expressing dTip60 E431Q B. Real-time PCR reactions were carried out in triplicate and the fold change was calculated using the ΔΔCT method using RP49 as control. Statistical significance was calculated using an unpaired Student's ttest. * P<0.05. (B) List of selected axonal transport related target genes and their functions that are identified in microarray analysis and validated in larval brain tissue using quantitative RT-PCR. (A) Real time PCR was carried out on cDNA isolated from staged third instar larval dissected brain tissue from either ms-275 treated or untreated larvae expressing dTip60 E431Q using the elav C155 pan-neuronal GAL4 driver. Each histogram bar represents the fold change in expression level of axonal transport related target genes in brains of larvae expressing either dTip60 E431Q B or dTip60 E431Q B larvae treated with ms-275 relative to w 1118 control flies. Real-time PCR reactions were carried out in triplicate and the fold change was calculated using the ΔΔCT method using RP49 as control. Asterisks above Appl and Syt1 denotes significant fold changes in gene targets between treated larvae and untreated larvae, indicating partial rescue of expression with ms-275 for these genes. Statistical significance was calculated using an unpaired Student's t-test. * P<0.05. (B) Chromatin was isolated from 300 pooled larvae heads for each of the indicated genotypes. Chromatin precipitation (ChIP) was performed using ChIP-IT Express Kit (Active Motif) using Tip60 antibodies and (C) Pan-acetylated histone H4 antibodies. For each ChIP experiment, a mock reaction containing no antibody was carried out simultaneously as a negative control. Real-time PCR was performed on DNA purified from each of the ChIP reactions using primer pairs specific for each gene loci. Fold enrichment of the respective genes was calculated relative to the mock no antibody control using the standard curve method as described in the ChIP-IT Express Kit manual. Dotted line in (A) represents baseline enrichment level set by using negative control primers that amplify a fragment within a gene desert within Drosophila chromosome 3L. All data are from three independent qPCR experiments for each genotype. Statistical significance for all experiments was calculated using an unpaired Student's t-test. *P≤0.05; **P≤0.01; ***P≤0.001; values are mean ± s.e.m. 
